| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1196/ANNALS.1423.023 |
| P698 | PubMed publication ID | 17911436 |
| P50 | author | Michael R. Hayden | Q6833706 |
| William T. Gibson | Q42873515 | ||
| P2093 | author name string | Michael Reuben Hayden | |
| William Thomas Gibson | |||
| P2860 | cites work | Apoptosis of superantigen-activated T cells induced by mycophenolate mofetil treatment | Q32041175 |
| Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
| Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
| Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients | Q34156177 | ||
| The design and development of an immunosuppressive drug, mycophenolate mofetil | Q34350677 | ||
| Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management | Q35179614 | ||
| Cardiovascular disease in systemic lupus erythematosus: has the time for action come? | Q36251696 | ||
| Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection | Q36298271 | ||
| Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles? | Q36313446 | ||
| Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil | Q38324351 | ||
| Two lessons from the interface of genetics and medicine | Q42426745 | ||
| Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts | Q42555924 | ||
| Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models | Q43620667 | ||
| Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS/ISHLT Thoracic Registry | Q43811358 | ||
| Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection | Q44146546 | ||
| Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial | Q44157655 | ||
| Treatment by mycophenolate mofetil of advanced graft vascular disease in non-human primate recipients of orthotopic aortic allografts | Q44482852 | ||
| Mycophenolate mofetil significantly reduces leukocyte graft infiltration after heterotopic cardiac transplantation in a rat model: comparative study with cyclosporine and FK 506 | Q44612737 | ||
| Mycophenolate mofetil for secondary prevention of cardiac allograft vasculopathy: influence on inflammation and progression of intimal hyperplasia | Q44735498 | ||
| Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation | Q44940055 | ||
| Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts | Q45069261 | ||
| Reduction of ICAM-1 and LFA-1-positive leukocytes in the perivascular space of arteries under mycophenolate mofetil therapy reduces rat heart transplant vasculopathy | Q45193247 | ||
| Advancing immunosuppression therapy to counter the progression of cardiac allograft vasculopathy | Q45283117 | ||
| Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes | Q45289903 | ||
| A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. | Q46186465 | ||
| Vascular remodeling 1 year after cardiac transplantation. | Q46394182 | ||
| Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. | Q46492984 | ||
| Effects of mycophenolate mofetil on cardiac allograft survival and cardiac allograft vasculopathy in miniature swine | Q46768228 | ||
| Mycophenolate mofetil reduces production of interferon-dependent major histocompatibility complex induction during allograft rejection, probably by limiting clonal expansion | Q47926348 | ||
| Effect of mycophenolate mofetil on atherosclerosis in a rabbit model: initial histologic and immunohistochemical analyses | Q47940633 | ||
| Cardiac allograft vasculopathy in heart transplant patients: pathologic and clinical aspects for angioplasty/stenting. | Q51154236 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 209-221 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Mycophenolate mofetil and atherosclerosis: results of animal and human studies | |
| P478 | volume | 1110 |
| Q43254730 | Arteriolar hyalinization in implantation kidney biopsies as a predictor of graft function |
| Q35525108 | Atherosclerosis in systemic lupus erythematosus |
| Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
| Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
| Q35835882 | Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice |
| Q36043804 | Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation |
| Q38585887 | Mycophenolate mofetil for lupus nephritis: an update |
| Q39077512 | Mycophenolic acid attenuates the tumour necrosis factor-α-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-κB and ROS pathways |
| Q38230699 | Pathogenesis and treatment of atherosclerosis in lupus |
| Q37573524 | Premature vascular damage in systemic lupus erythematosus |
| Q37549027 | Premature vascular damage in systemic lupus erythematosus: an imbalance of damage and repair? |
| Q28486062 | The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus |
| Q35169351 | The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus |
Search more.